Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement

  • Kline, A.D.
  • Moss, J.F.
  • Selicorni, A.
  • Bisgaard, A.M.
  • Deardorff, M.A.
  • Gillett, P.M.
  • Ishman, S.L.
  • Kerr, L.M.
  • Levin, A.V.
  • Mulder, P.A.
  • Ramos, F.J.
  • Wierzba, Jl
  • Ajmone, P.F.
  • Axtell, D.
  • Blagowidow, N.
  • Cereda, A.
  • Costantino, A.
  • Cormier-Daire, V.
  • FitzPatrick, D.
  • Grados, M.
  • Groves, L.
  • Guthrie, W.
  • Huisman, S.
  • Kaiser, F.J.
  • Koekkoek, G.
  • Levis, M.
  • Mariani, M.
  • McCleery, J.P.
  • Menke, L.A.
  • Metrena, A
  • O'Connor, J.
  • Oliver, C.
  • Pie, J.
  • Piening, S.
  • Potter, C.J.
  • Quaglio, A.L.
  • Redeker, E.
  • Richman, D.
  • Rigamonti, C.
  • Shi, A.
  • Tümer, Z.
  • Van Balkom, I.D.C.
  • Hennekam, R.C.
Cornelia de Lange syndrome (CdLS) is an archetypical genetic syndrome that is characterized by intellectual disability, well-defined facial features, upper limb anomalies and atypical growth, among numerous other signs and symptoms. It is caused by variants in any one of seven genes, all of which have a structural or regulatory function in the cohesin complex. Although recent advances in next-generation sequencing have improved molecular diagnostics, marked heterogeneity exists in clinical and molecular diagnostic approaches and care practices worldwide. Here, we outline a series of recommendations that document the consensus of a group of international experts on clinical diagnostic criteria, both for classic CdLS and non-classic CdLS phenotypes, molecular investigations, long-term management and care planning.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies

  • Prieto-Torres, L.
  • Rodriguez-Pinilla, S.M.
  • Onaindia, A.
  • Ara, M.
  • Requena, L.
  • Piris, M.Á.
Primary cutaneous CD30-positive T-cell lymphoproliferative disorders are the second most common subgroup of cutaneous T-cell lymphomas. They include two clinically different entities with some overlapping features and borderline cases: lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. Molecular studies of primary cutaneous anaplastic large cell lymphoma reveal an increasing level of heterogeneity that is associated with histological and immunophenotypic features of the cases and their response to specific therapies. Here, we review the most significant genetic, epigenetic and molecular alterations described to date in primary cutaneous CD30-positive T-cell lymphoproliferative disorders, and their potential as therapeutic targets.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

Health care services use among long-term breast cancer survivors: a systematic review

  • Jansana, A.
  • Posso, M.
  • Guerrero, I.
  • Prados-Torres, A.
  • Del Cura, M.I.
  • Castells, X.
  • Sala, M.
Purpose: Long-term breast cancer survivors are women surviving at least 5 years after diagnosis. This systematic review aimed to summarize the main characteristics and patterns of healthcare service use (frequency of visits, health providers visited, and preventive care performed) among long-term breast cancer survivors. Methods: We used standard Cochrane Collaboration methods and searched the MEDLINE and EMBASE databases up to January 2018. We included English language observational studies reporting health service use among long-term cancer survivors. The quality of the studies was appraised through the ROBINS-I assessment tool. Two independent reviewers performed both the study quality assessment and the data extraction. Results: A total of 23 observational studies were included that reported data on health services use by long-term breast cancer survivors. Despite heterogeneity among studies, about half of them reported that breast cancer survivors visited a medical provider at least once a year, as recommended by breast cancer survival guidelines. Although survivors visited medical providers with the recommended frequency, a substantial number used specialist care instead of primary care during follow-up. The results showed underuse of the recommended annual mammogram. Conclusions: Long-term breast cancer survivors differ in their health services use with regard to the frequency of visits as well as the health providers seen. Our results indicate the need for active surveillance through primary care providers in coordination with specialized care. Implications for cancer survivors: This review could help to standardize the management of breast cancer survivors and decision-makers to adapt their guidelines and clinical protocols.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

The role of extracellular matrix on liver stem cell fate: A dynamic relationship in health and disease

  • Sánchez-Romero, N.
  • Sainz-Arnal, P.
  • Pla-Palacín, I.
  • Royo Dachary, P.
  • Almeida, H.
  • Pastor, C.
  • Rubio Soto, D.
  • Chico Rodriguez, M.
  • Olmedo Arbizu, E.
  • Bengochea Martinez, L.
  • Serrano-Aulló, T.
  • Baptista, P.M.
The liver stem cell niche is a specialized and dynamic microenvironment with biomechanical and biochemical characteristics that regulate stem cell behavior. This is feasible due to the coordination of a complex network of secreted factors, small molecules, neural, blood inputs and extracellular matrix (ECM) components involved in the regulation of stem cell fate (self-renewal, survival, and differentiation into more mature phenotypes like hepatocytes and cholangiocytes). In this review, we describe and summarize all the major components that play essential roles in the liver stem cell niche, in particular, growth factor signaling and the biomechanical properties of the ECM.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma

  • Santofimia-Castaño, P.
  • Xia, Y.
  • Peng, L.
  • Velázquez-Campoy, A.
  • Abián, O.
  • Lan, W.
  • Lomberk, G.
  • Urrutia, R.
  • Rizzuti, B.
  • Soubeyran, P.
  • Neira, J.L.
  • Iovanna, J.
Cancer cells activate stress-response mechanisms to adapt themselves to a variety of stressful conditions. Among these protective mechanisms, those controlled by the stress-induced nuclear protein 1 (NUPR1 ) belong to the most conserved ones. NUPR1 is an 82-residue-long, monomeric, basic and intrinsically disordered protein (IDP), which was found to be invariably overexpressed in some, if not all, cancer tissues. Remarkably, we and others have previously showed that genetic inactivation of the Nupr1 gene antagonizes the growth of pancreatic cancer as well as several other tumors. With the use of a multidisciplinary strategy by combining biophysical, biochemical, bioinformatic, and biological approaches, a trifluoperazine-derived compound, named ZZW-115, has been identified as an inhibitor of the NUPR1 functions. The anticancer activity of the ZZW-115 was first validated on a large panel of cancer cells. Furthermore, ZZW-115 produced a dose-dependent tumor regression of the tumor size in xenografted mice. Mechanistically, we have demonstrated that NUPR1 binds to several importins. Because ZZW-115 binds NUPR1 through the region around the amino acid Thr68, which is located into the nuclear location signal (NLS) region of the protein, we demonstrated that treatment with ZZW-115 inhibits completely the translocation of NUPR1 from the cytoplasm to the nucleus by competing with importins.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

Neoplasia-associated wasting diseases with economic relevance in the sheep industry

  • De las Heras, M.
  • Borobia, M.
  • Ortín, A.
We review three neoplastic wasting diseases affecting sheep generally recorded under common production cycles and with epidemiological and economic relevance in sheep-rearing countries: small intestinal adenocarcinoma (SIA), ovine pulmonary adenocarcinoma (OPA) and enzootic nasal adenocarcinoma (ENA). SIA is prevalent in Australia and New Zealand but present elsewhere in the world. This neoplasia is a tubular or signet-ring adenocarcinoma mainly located in the middle or distal term of the small intestine. Predisposing factors and aetiology are not known, but genetic factors or environmental carcinogens may be involved. OPA is a contagious lung cancer caused by jaagsiekte sheep retrovirus (JSRV) and has been reported in most sheep-rearing countries, resulting in significant economic losses. The disease is clinically characterized by a chronic respiratory process as a consequence of the development of lung adenocarcinoma. Diagnosis is based on the detection of JSRV in the tumour lesion by immunohistochemistry and PCR. In vivo diagnosis may be difficult, mainly in preclinical cases. ENA is a neoplasia of glands of the nasal mucosa and is associated with enzootic nasal tumour virus 1 (ENTV-1), which is similar to JSRV. ENA enzootically occurs in many countries of the world with the exception of Australia and New Zealand. The pathology associated with this neoplasia corresponds with a space occupying lesion histologically characterized as a low-grade adenocarcinoma. The combination of PCR and immunohistochemistry for diagnosis is advised.